American International Group’s Agile Therapeutics AGRX Stock Holding History

American International Group’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20	Closed	-$82K	–	3333
2021 Q1	$82K	Hold	20	–	–	﹤0.01%	2807
2020 Q4	$113K	Hold	20	–	–	﹤0.01%	2594
2020 Q3	$123K	Sell	20 -1	-5%	-$5.73K	﹤0.01%	2416
2020 Q2	$115K	Buy	+21	New	+$109K	﹤0.01%	2444
2017 Q2	–	Sell	-4	Closed	-$26K	–	3138
2017 Q1	$26K	Hold	4	–	–	﹤0.01%	2937
2016 Q4	$44K	Hold	4	–	–	﹤0.01%	2882
2016 Q3	$53.4K	Hold	4	–	–	﹤0.01%	2881
2016 Q2	$58.2K	Buy	4 +1	+33%	+$13.7K	﹤0.01%	2910
2016 Q1	$38K	Hold	3	–	–	﹤0.01%	4020
2015 Q4	$59K	Hold	3	–	–	﹤0.01%	3826
2015 Q3	$41K	Hold	3	–	–	﹤0.01%	3999
2015 Q2	$52.4K	Buy	+3	New	+$64K	﹤0.01%	4032

Other funds holding AGRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's AGRX Position: Q2 2021 in Review

American International Group sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 20 shares — an estimated $82K sold.

American International Group first reported a position in AGRX in Q2 2015 and held it in 12 quarters. The position peaked at $123K in Q3 2020. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

American International Group reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
American International Group sold 20 Agile Therapeutics shares in Q2 2021, an estimated $82K.
American International Group first reported a position in Agile Therapeutics in Q2 2015 and held it in 12 quarters.
American International Group's Agile Therapeutics position peaked at $123K in Q3 2020.
64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.